Masato Ishigami Selected Research

Apolipoprotein E3

1/2011

A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masato Ishigami Research Topics

Disease

9	Atherosclerosis 12/2012 - 06/2003
9	Hyperlipidemias (Hyperlipidemia) 09/2012 - 05/2007
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 06/2007
6	Hypertriglyceridemia 01/2013 - 05/2007
5	Platelet Glycoprotein IV Deficiency 01/2012 - 05/2003
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012 - 05/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2012 - 10/2007
3	Insulin Resistance 12/2012 - 05/2003
3	Coronary Disease (Coronary Heart Disease) 09/2011 - 03/2005
3	Hyperlipoproteinemia Type III (Broad Beta Disease) 12/2009 - 06/2003
3	Tangier Disease 06/2009 - 08/2002
2	Dyslipidemias (Dyslipidemia) 01/2011 - 05/2009
2	Obesity 09/2010 - 03/2005
2	Hypertension (High Blood Pressure) 05/2009 - 05/2007
2	Takayasu Arteritis (Arteritis, Takayasu's) 09/2005 - 09/2003
1	Neoplasms (Cancer) 06/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 09/2012
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2012
1	Hyperthyroidism 01/2012
1	Hypothyroidism 01/2012
1	Inflammation (Inflammations) 01/2012
1	Thyroid Diseases (Thyroid Disease) 01/2012
1	Lipoprotein Glomerulopathy 01/2011
1	Rare Diseases (Rare Disease) 01/2011
1	Hyperlipoproteinemias 01/2010
1	Xanthomatosis (Xanthoma) 01/2010
1	Pancreatitis 01/2010
1	Hyperglycemia 05/2009
1	Hypoadiponectinemia 10/2007
1	Atherosclerotic Plaque (Atheroma) 07/2007
1	Abdominal Obesity 03/2005
1	Cholesteryl Ester Transfer Protein Deficiency 01/2003
1	Fatty Liver 02/2002
1	Alcoholic Fatty Liver 02/2002
1	Hepatocellular Carcinoma (Hepatoma) 02/2002

Drug/Important Bio-Agent (IBA)

11	Lipoproteins (Lipoprotein)IBA 12/2012 - 05/2003
9	HDL LipoproteinsIBA 01/2018 - 08/2002
6	Apolipoprotein B-48IBA 09/2012 - 01/2011
5	CholesterolIBA 12/2012 - 03/2005
5	Triglycerides (Triacylglycerol)IBA 01/2012 - 12/2007
4	oxidized low density lipoproteinIBA 12/2012 - 05/2007
4	ApolipoproteinsIBA 09/2012 - 02/2002
4	HDL CholesterolIBA 06/2010 - 07/2007
3	AdiponectinIBA 12/2012 - 07/2007
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2008 - 07/2007
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2013 - 01/2010
2	Glucose (Dextrose)FDA LinkGeneric 09/2012 - 05/2007
2	Biomarkers (Surrogate Marker)IBA 09/2012 - 07/2011
2	ChylomicronsIBA 09/2012 - 09/2011
2	Chylomicron RemnantsIBA 09/2012 - 05/2009
2	polyacrylamideIBA 01/2011 - 12/2009
1	Proteins (Proteins, Gene)FDA Link 06/2022
1	human ERBB2 proteinIBA 06/2022
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 06/2022
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2013
1	high density lipoprotein binding proteinIBA 01/2013
1	hydroxide ionIBA 01/2012
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2012
1	AntioxidantsIBA 01/2012
1	Probucol (Lorelco)FDA Link 01/2012
1	Thyroid HormonesIBA 01/2012
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2012
1	CD36 AntigensIBA 01/2012
1	lipoprotein cholesterolIBA 07/2011
1	ORALIT (ORS)IBA 07/2011
1	Apolipoproteins E (ApoE)IBA 01/2011
1	Apolipoprotein E3IBA 01/2011
1	Ezetimibe (Zetia)FDA Link 09/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2010
1	Fenofibrate (CiL)FDA LinkGeneric 06/2010
1	Lipase (Acid Lipase)FDA Link 01/2010
1	BezafibrateIBA 01/2010
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2009
1	Cholesterol Esters (Cholesteryl Esters)IBA 06/2009
1	PPAR gammaIBA 10/2008
1	IDL Lipoproteins (Lipoprotein, IDL)IBA 04/2008
1	LigandsIBA 05/2007
1	NF-kappa B (NF-kB)IBA 05/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007
1	Minocycline (Cyclops)FDA LinkGeneric 09/2005
1	Matrix Metalloproteinases (MMPs)IBA 09/2003
1	Atorvastatin (Lipitor)FDA Link 06/2003
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2003
1	Cholesterol Ester Transfer ProteinsIBA 01/2003
1	Adenosine Triphosphate (ATP)IBA 08/2002
1	microsomal triglyceride transfer proteinIBA 02/2002
1	Ethanol (Ethyl Alcohol)IBA 02/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 06/2022
1	Therapeutics 06/2022